Cargando…
A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition
BACKGROUND: Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital- and community-acquired infections, including sepsis, liver abscess, and pneumonia, driven mainly by the emergence of successful high-risk clonal lineages. The K. pneumoniae sequence type (ST) 307 lineage has appear...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724794/ https://www.ncbi.nlm.nih.gov/pubmed/33298160 http://dx.doi.org/10.1186/s13073-020-00814-6 |
_version_ | 1783620590415904768 |
---|---|
author | Heiden, Stefan E. Hübner, Nils-Olaf Bohnert, Jürgen A. Heidecke, Claus-Dieter Kramer, Axel Balau, Veronika Gierer, Wolfgang Schaefer, Stephan Eckmanns, Tim Gatermann, Sören Eger, Elias Guenther, Sebastian Becker, Karsten Schaufler, Katharina |
author_facet | Heiden, Stefan E. Hübner, Nils-Olaf Bohnert, Jürgen A. Heidecke, Claus-Dieter Kramer, Axel Balau, Veronika Gierer, Wolfgang Schaefer, Stephan Eckmanns, Tim Gatermann, Sören Eger, Elias Guenther, Sebastian Becker, Karsten Schaufler, Katharina |
author_sort | Heiden, Stefan E. |
collection | PubMed |
description | BACKGROUND: Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital- and community-acquired infections, including sepsis, liver abscess, and pneumonia, driven mainly by the emergence of successful high-risk clonal lineages. The K. pneumoniae sequence type (ST) 307 lineage has appeared in several different parts of the world after first being described in Europe in 2008. From June to October 2019, we recorded an outbreak of an extensively drug-resistant ST307 lineage in four medical facilities in north-eastern Germany. METHODS: Here, we investigated these isolates and those from subsequent cases in the same facilities. We performed whole-genome sequencing to study phylogenetics, microevolution, and plasmid transmission, as well as phenotypic experiments including growth curves, hypermucoviscosity, siderophore secretion, biofilm formation, desiccation resilience, serum survival, and heavy metal resistance for an in-depth characterization of this outbreak clone. RESULTS: Phylogenetics suggest a homogenous phylogram with several sub-clades containing either isolates from only one patient or isolates originating from different patients, suggesting inter-patient transmission. We identified three large resistance plasmids, carrying either NDM-1, CTX-M-15, or OXA-48, which K. pneumoniae ST307 likely donated to other K. pneumoniae isolates of different STs and even other bacterial species (e.g., Enterobacter cloacae) within the clinical settings. Several chromosomally and plasmid-encoded, hypervirulence-associated virulence factors (e.g., yersiniabactin, metabolite transporter, aerobactin, and heavy metal resistance genes) were identified in addition. While growth, biofilm formation, desiccation resilience, serum survival, and heavy metal resistance were comparable to several control strains, results from siderophore secretion and hypermucoviscosity experiments revealed superiority of the ST307 clone, similar to an archetypical, hypervirulent K. pneumoniae strain (hvKP1). CONCLUSIONS: The combination of extensive drug resistance and virulence, partly conferred through a “mosaic” plasmid carrying both antibiotic resistance and hypervirulence-associated features, demonstrates serious public health implications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-020-00814-6. |
format | Online Article Text |
id | pubmed-7724794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-77247942020-12-09 A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition Heiden, Stefan E. Hübner, Nils-Olaf Bohnert, Jürgen A. Heidecke, Claus-Dieter Kramer, Axel Balau, Veronika Gierer, Wolfgang Schaefer, Stephan Eckmanns, Tim Gatermann, Sören Eger, Elias Guenther, Sebastian Becker, Karsten Schaufler, Katharina Genome Med Research BACKGROUND: Antibiotic-resistant Klebsiella pneumoniae are a major cause of hospital- and community-acquired infections, including sepsis, liver abscess, and pneumonia, driven mainly by the emergence of successful high-risk clonal lineages. The K. pneumoniae sequence type (ST) 307 lineage has appeared in several different parts of the world after first being described in Europe in 2008. From June to October 2019, we recorded an outbreak of an extensively drug-resistant ST307 lineage in four medical facilities in north-eastern Germany. METHODS: Here, we investigated these isolates and those from subsequent cases in the same facilities. We performed whole-genome sequencing to study phylogenetics, microevolution, and plasmid transmission, as well as phenotypic experiments including growth curves, hypermucoviscosity, siderophore secretion, biofilm formation, desiccation resilience, serum survival, and heavy metal resistance for an in-depth characterization of this outbreak clone. RESULTS: Phylogenetics suggest a homogenous phylogram with several sub-clades containing either isolates from only one patient or isolates originating from different patients, suggesting inter-patient transmission. We identified three large resistance plasmids, carrying either NDM-1, CTX-M-15, or OXA-48, which K. pneumoniae ST307 likely donated to other K. pneumoniae isolates of different STs and even other bacterial species (e.g., Enterobacter cloacae) within the clinical settings. Several chromosomally and plasmid-encoded, hypervirulence-associated virulence factors (e.g., yersiniabactin, metabolite transporter, aerobactin, and heavy metal resistance genes) were identified in addition. While growth, biofilm formation, desiccation resilience, serum survival, and heavy metal resistance were comparable to several control strains, results from siderophore secretion and hypermucoviscosity experiments revealed superiority of the ST307 clone, similar to an archetypical, hypervirulent K. pneumoniae strain (hvKP1). CONCLUSIONS: The combination of extensive drug resistance and virulence, partly conferred through a “mosaic” plasmid carrying both antibiotic resistance and hypervirulence-associated features, demonstrates serious public health implications. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13073-020-00814-6. BioMed Central 2020-12-09 /pmc/articles/PMC7724794/ /pubmed/33298160 http://dx.doi.org/10.1186/s13073-020-00814-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Heiden, Stefan E. Hübner, Nils-Olaf Bohnert, Jürgen A. Heidecke, Claus-Dieter Kramer, Axel Balau, Veronika Gierer, Wolfgang Schaefer, Stephan Eckmanns, Tim Gatermann, Sören Eger, Elias Guenther, Sebastian Becker, Karsten Schaufler, Katharina A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition |
title | A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition |
title_full | A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition |
title_fullStr | A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition |
title_full_unstemmed | A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition |
title_short | A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition |
title_sort | klebsiella pneumoniae st307 outbreak clone from germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724794/ https://www.ncbi.nlm.nih.gov/pubmed/33298160 http://dx.doi.org/10.1186/s13073-020-00814-6 |
work_keys_str_mv | AT heidenstefane aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT hubnernilsolaf aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT bohnertjurgena aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT heideckeclausdieter aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT krameraxel aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT balauveronika aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT giererwolfgang aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT schaeferstephan aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT eckmannstim aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT gatermannsoren aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT egerelias aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT guenthersebastian aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT beckerkarsten aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT schauflerkatharina aklebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT heidenstefane klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT hubnernilsolaf klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT bohnertjurgena klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT heideckeclausdieter klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT krameraxel klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT balauveronika klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT giererwolfgang klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT schaeferstephan klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT eckmannstim klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT gatermannsoren klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT egerelias klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT guenthersebastian klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT beckerkarsten klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition AT schauflerkatharina klebsiellapneumoniaest307outbreakclonefromgermanydemonstratesfeaturesofextensivedrugresistancehypermucoviscosityandenhancedironacquisition |